Aligos Therapeutics Cash Flow Statement (2019-2026)

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Operating Activities
Net Income (Quarter)	-33.12M	-37.71M	-35.62M	-19.92M	-18.62M	-21.89M	-22.95M	-18.79M	-18.04M	-27.89M	-34.86M	5.06M	-19.26M	-82.15M	43.09M	-15.86M	-31.54M	-19.88M	-23.04M	-1.50M
Depreciation and Depletion (Quarter)	0.80M	0.71M	0.68M	0.60M	0.50M	0.51M	0.45M	0.40M	0.30M	0.40M	0.28M	0.30M	0.30M	0.24M	0.19M	0.30M	0.20M	0.20M	0.35M	0.30M
Share-based Compensation (Quarter)	3.59M	-7.16M	0.44M	0.45M	3.49M	-9.98M	3.66M	0.22M	3.21M	2.58M	0.15M	0.14M	0.14M	-6.24M	0.05M	0.11M	0.20M	-3.08M	1.31M	1.36M
Gains from Investment Securities (Quarter)											14.37M	-30.48M	0.10M	62.13M	-61.49M	-1.68M	4.21M	-1.21M	-3.40M	-2.98M
Asset Writedowns and Impairment (Quarter)								0.70M
Cash from Operations (Quarter)	-25.37M	-37.48M	-20.43M	-25.04M	-17.14M	-16.78M	-22.39M	-13.62M	-20.34M	-22.66M	-22.75M	-19.49M	-20.10M	-18.40M	-20.91M	-15.50M	-24.34M	-21.75M	-23.13M	-24.95M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)	-0.00M	-0.02M	-0.01M	0.02M	0.07M	0.07M	0.27M	0.16M			0.08M	0.85M	0.47M	0.37M	0.14M	0.90M	0.71M	0.44M	0.42M	0.07M
Amortization of Deferred Charges (Quarter)	0.19M	0.28M	0.31M	0.32M	0.37M	0.38M	0.39M	0.36M	0.37M	0.38M	0.39M	0.35M	0.42M	0.43M	0.32M	0.59M	0.48M	0.49M	0.51M	0.47M
Depreciation & Amortization (CF) (Quarter)	0.80M	0.71M	0.68M	0.60M	0.50M	0.51M	0.45M	0.40M	0.30M	0.40M	0.28M	0.30M	0.30M	0.24M	0.19M	0.30M	0.20M	0.20M	0.35M	0.30M
Change in Working Capital
Change in Account Payables (Quarter)	1.12M	0.40M	0.74M	-0.99M	0.17M	1.81M	-1.92M	0.42M	-0.30M	-0.42M	0.33M	3.98M	-4.08M	-0.17M	1.73M	-0.40M	0.75M	-0.67M	3.66M	-1.21M
Change in Accured Expenses (Quarter)	5.97M	-6.11M	-6.07M	-6.35M	0.90M	2.39M	-0.94M	-1.26M	-1.46M	3.70M	-4.80M	0.02M	2.10M	1.29M	-4.76M	1.41M	1.40M	-0.08M	-1.54M	6.71M
Other Working Capital Changes (Quarter)	0.04M	-4.62M	-0.05M	-5.55M	4.26M	-4.26M	-0.58M	-4.06M	2.83M	-0.49M	-0.59M	0.60M	-1.98M	0.81M	-0.15M	-1.35M	0.72M	0.63M	-0.32M	-0.83M
Investing Activities
Capital Expenditures (Quarter)	0.10M	-0.54M	0.52M	0.33M	0.00M	0.09M	0.01M
Change in Acquisitions & Divestments (Quarter)	3.00M	10.00M			37.45M	36.22M	20.00M	25.00M	0.01M				30.00M	20.00M	20.00M		70.00M	37.50M	35.00M	25.00M
Cash from Investing Activities (Quarter)	-0.04M	-16.48M	-60.40M	-9.98M	32.48M	11.60M	19.99M	25.00M	-0.01M	-0.01M	-88.64M	39.99M	10.40M	19.97M	-44.07M	-39.42M	47.68M	-2.02M	34.93M	25.00M
Financing Activities
Other financing activities (Quarter)	0.02M		0.01M	0.10M	-0.09M	0.18M	0.02M	0.44M		0.09M				0.14M				0.12M
Cash from Financing Activities (Quarter)	77.95M	0.55M	-0.02M	0.08M	-0.02M	0.12M	-0.00M	0.41M	-0.02M	87.94M	-0.02M	0.28M	-0.00M	0.10M	101.74M	-0.18M	-0.05M	0.12M	-0.06M	0.22M
Additional items
Change in Cash (Quarter)	52.54M	-53.41M	-80.86M	-34.93M	15.33M	-5.06M	-2.40M	11.80M	-20.37M	65.27M	-111.41M	20.78M	-9.71M	1.67M	36.77M	-55.10M	23.29M	-23.64M	11.74M	0.27M
Free Cash Flow (Quarter)	-25.46M	-36.94M	-20.95M	-25.37M	-17.14M	-16.87M	-22.39M	-13.62M	-20.34M	-22.66M	-22.75M	-19.49M	-20.10M	-18.40M	-20.91M	-15.50M	-24.34M	-21.75M	-23.13M	-24.95M
Net Cash Flow (Quarter)	52.54M	-53.41M	-80.86M	-34.93M	15.33M	-5.06M	-2.40M	11.80M	-20.37M	65.27M	-111.41M	20.78M	-9.71M	1.67M	36.77M	-55.10M	23.29M	-23.64M	11.74M	0.27M

Research Tools

Datasets

Plans

Developers

Aligos Therapeutics ALGS Cash Flow Statement (2019-2026)

Research Tools

Datasets

Plans

Developers

Aligos Therapeutics ALGS Cash Flow Statement (2019-2026)

Create an account

Sign In

Reset Password